Beijing Beilu Pharmaceutical Co., Ltd (300016.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap4.09B
Enterprise Value4.4B
P/E Ratio31.25
PEG Ratio0.06
Price/Sales Ratio3.56
Price/Book Ratio1.84
Enterprise/Revenue3.7
Enterprise/EBITDA17.6

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.11
Operating Margin0.1
AD

Management Effectiveness

Return On Assets0.04
Return On Equity0.06

Income Statement

Revenue1.2B
Revenue/Share2.23
Gross Profit513.49M
EBITDA251.31M
Net Income92.73M
Diluted EPS0.18

Balance Sheet

Total Cash882.32M
Total Cash/Share1.52
Total Debt620.82M
Total Debt/Equity0.25
Current Ratio2.64
Book Value Per Share4.59

Price History

52-Week Change-9.69
52-Week High11.38
52-Week Low7.08
Moving Average 50 Days8.88
Moving Average 200 Days9.06

Statistics

Average Volume32.69M
Shares Outstanding581.69M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.06
Trailing Annual Dividend Yield0.76
Payout Ratio0.05
Last Split Factor3:2
Last Split DateSeptember 04, 2018
AD